EDGAR Filing Documents for 0000945621-13-000351

Form D/A - Notice of Exempt Offering of Securities: [Amend]

SEC Accession No. 0000945621-13-000351

Filing Date

2013-11-26

Accepted

2013-11-26 12:25:15

Documents

Effectiveness Date

2013-11-26

Items

Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.1: Section 3(c)(1)

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	D/A
1		primary_doc.xml	D/A	9200
	Complete submission text file	0000945621-13-000351.txt		10832

Mailing Address C/O ESSEX INVESTMENT MANAGEMENT CO., LLC 125 HIGH ST BOSTON MA 02110

Business Address C/O ESSEX INVESTMENT MANAGEMENT CO., LLC 125 HIGH ST BOSTON MA 02110 617-342-3200

Essex Global Life Sciences Fund, LP (Filer) CIK: 0001505786 (see all company filings)